Standout Papers

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Pati... 1999 2026 2008 2017 1.6k
  1. A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate (1999)
    Michael E. Weinblatt, Joel M. Kremer et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 11 from Science/Nature 113 standout
Sub-graph 1 of 15

Citing Papers

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
2021 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
2 intermediate papers

Works of M. Lange being referenced

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout

Author Peers

Author Last Decade Papers Cites
M. Lange 1628 563 922 7 2.2k
Linda M. Katz 1869 527 889 13 2.5k
M V van Krugten 1630 421 636 19 2.0k
Scott W. Baumgartner 1327 758 985 18 2.4k
Valerie Nell 2299 351 888 19 2.7k
Matthew Cravets 1077 604 455 6 1.9k
John Han 1818 741 819 20 2.3k
J-C Becker 1648 478 740 17 2.0k
L. Settas 1447 424 661 19 2.0k
Marie Sanda 1395 331 602 14 1.8k
William Shergy 1215 555 478 24 1.8k

All Works

Loading papers...

Rankless by CCL
2026